BioNTech SE
BNTX
$99.47
$2.012.06%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 217.79M | -869.46M | -342.07M | 492.97M | 174.80M |
| Total Depreciation and Amortization | 48.81M | 53.71M | 41.58M | 84.83M | 44.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -226.58M | 20.88M | -285.51M | 1.20B | -32.76M |
| Change in Net Operating Assets | -742.41M | 2.55B | 241.54M | -865.35M | 695.94M |
| Cash from Operations | -702.39M | 1.75B | -344.46M | 916.06M | 882.93M |
| Capital Expenditure | -80.03M | -95.36M | -63.51M | -90.11M | -58.77M |
| Sale of Property, Plant, and Equipment | 329.80K | 215.30K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | -366.69M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -76.52M | -164.68M | -2.44B | -2.81B | -915.69M |
| Cash from Investing | -156.22M | -259.83M | -2.50B | -2.90B | -1.34B |
| Total Debt Issued | -- | -- | -- | 200.00K | 100.00K |
| Total Debt Repaid | -7.90M | -22.90M | -7.80M | -12.30M | -9.40M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -800.00K | -301.70M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.69M | -24.65M | -8.47M | -13.89M | -338.50M |
| Foreign Exchange rate Adjustments | -2.53M | -3.55M | 7.38M | -150.51M | 66.61M |
| Miscellaneous Cash Flow Adjustments | 42.99M | 43.59M | -69.91M | 177.42M | -- |
| Net Change in Cash | -826.84M | 1.51B | -2.92B | -1.97B | -730.11M |
